BridgeMD
Compares treatment options for Patello Femoral Pain Syndrome
Official title Comparative Effects of Blood Flow Restriction Resistance Training Versus Blood Flow Restriction Cycling on Pain, Quadriceps Strength, and Functional Outcomes in Athletes With Patellofemoral Pain
ClinicalTrials.gov ID: NCT07585305
What this study is testing
- What it's testing
- This randomized controlled trial compares blood flow restriction (BFR) resistance training (leg press and seated knee extension at 30% 1RM) versus BFR cycling (stationary cycling at low resistance) in 60 athletes (aged 18-40 years) diagnosed with patellofemoral pain syndrome. Both interventions are delivered over 8 weeks (3 sessions/week) with a pneumatic cuff set at 80% limb occlusion pressure.
- Time commitment: about 8 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40
You may be able to join if
- Male and female athletes aged 18-40 years
- Clinically diagnosed with patellofemoral pain syndrome
- Anterior or retropatellar knee pain of at least 3 months duration
- Pain provoked by at least two functional activities (e.g., squatting, stair climbing, running, prolonged sitting)
- Willingness to participate and provide written informed consent
You likely can't join if
- History of knee surgery or significant knee trauma in the past 6 months
- Presence of ligament, meniscal, or cartilage injuries
- Neurological, vascular, or systemic inflammatory conditions
- Contraindications to BFR training (e.g., deep vein thrombosis, uncontrolled hypertension)
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Islamabad, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 8 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Islamabad, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.